Insitro

About:

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Website: http://www.insitro.com

Twitter/X: insitro

Top Investors: BlackRock, Andreessen Horowitz, CPP Investments, WuXi AppTec, Mubadala

Description:

Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from bioengineering enabling it to generate high-throughput, functional genomic data sets and aligning them with patient data via novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics. In 2018, Daphne Koller established Insitro in South San Francisco, California..